Get Consumer Devices every Monday

One free email with what the biggest companies in Consumer Devices filed, were granted and gave up this week.

The Thicket.
Consumer Devices / Week of Nov 16, 2026Get it every Monday →
All Consumer DevicesIssue 001 / Apple Inc.The filing
Apple Inc.Grant

Apple Inc. secures US patent for wearable PPG device with multiple light paths and obscured optics.

The filing

Apple Inc. received a US grant on November 10, 2026 for a wearable device that uses multiple light paths and obscured optics to balance signal strength with motion rejection. The applicant describes the device as using Fresnel lenses and ridges to hide emitters and wiring from the user's eye while minimizing crosstalk. The original set of twenty claims was cancelled, and the examiner rejected claims covering the method of determining physiological information under 35 U.S.C. 112, leaving the granted patent to cover the specific wearable device architecture with the described optical arrangement.

The claims

USPTO 12,791,476 / 4 independent claims of 20

  1. Claim 1Canceled

    1-20. (Canceled)

  2. Claim 21Previously presented

    A wearable electronic device comprising: a strap; a housing; a photoplethysmographic device comprising: a first light detector; a first light emitter; a first window, wherein the first light detector is positioned behind the first window ; a first Fresnel lens positioned between the first window and the first light detector ; a second window, wherein the first light emitter is positioned behind and off- center with respect to the second window; and a second Fresnel lens positioned between the second window and the first light emitter and comprising: a first zone that is positioned above the first emitter and configured to collimate light emitted by the first emitter; and a second zone that includes ridges that act to obscure components underlying the second zone.

  3. Claim 28Previously presented

    A wearable electronic device comprising: a first light detector and a first light emitter mounted to a component mounting plane; an optical isolation positioned between first light detector and the first emitter; a first window, wherein the first light detector is positioned behind the first window ; a first Fresnel lens positioned between the first window and the first light detector ; a second window, wherein the first light emitter is positioned behind and off- center with respect to the second window; and a second Fresnel lens positioned between the second window and the first light emitter and comprising: a first zone that is positioned above the first emitter and configured to collimate light emitted by the first emitter; and a second zone that includes ridges that act to obscure components underlying the second zone.

  4. Claim 36Previously presented

    A method of determining physiological information of a user, the method comprising: at a device comprising: a first light detector and a first light emitter mounted to a component mounting plane; an optical isolation positioned between first light detector and the first emitter; a first window, wherein the first light detector is positioned behind the first wi ndow ; a first Fresnel lens positioned between the first window and the first light detector ; a second window, wherein the first light emitter is positioned behind and off- center with respect to the second window; and a second Fresnel lens positioned between the second window and the first light emitter and comprising: a first zone that is positioned above the first emitter and configured to collimate light emitted by the first emitter; and a second zone that includes ridges that act to obscure components underlying the second zone: emitting light from the first light emitter; receiving a first portion of the emitted light by the first light detector; determining the physiological information using the received first portion of the emitted light.

The 16 dependent claims are in the record. Open the record (opens in a new tab)

Examiner rulings

  • Non-Final Rejection, : Claims 37-38 rejected (35 U.S.C. 112)

Expert view

Apple Inc. received a US grant on November 10, 2026 for a wearable electronic device designed to optimize photoplethysmographic (PPG) signal quality and perfusion index across varying user conditions. The invention addresses the trade-off where shorter emitter-detector distances yield strong signals but poor motion rejection, while longer distances improve motion performance but reduce signal strength, by employing multiple light paths with different separation distances and locations. The device uses Fresnel lenses to collimate light and includes ridges on a second lens zone to obscure the underlying emitters, detectors, and wiring from the user's eye, while optical isolation separates the components to minimize crosstalk. The original set of twenty claims was cancelled, and the examiner rejected claims covering the method of determining physiological information under 35 U.S.C. 112, leaving the granted patent to cover the specific wearable device architecture with the described optical arrangement.

Background

The applicant’s account of the prior art / USPTO 12,791,476

A photoplethysmographic (PPG) signal can be measured by PPG systems to derive corresponding physiological signals (e.g., pulse rate). In a basic form, PPG systems can employ a light source or light emitter that injects light into the user’s tissue and a light detector to receive light that reflects and/or scatters and exits the tissue. The received light includes light with an amplitude that is modulated as a result of pulsatile blood flow (i.e., “signal”) and parasitic, non-signal light with an amplitude that can be modulated (i.e., “noise” or “artifacts”) and/or unmodulated (i.e., DC). Noise can be introduced by, for example tilt and/or pull of the device relative to the user’s tissue, hair, and/or motion. For a given light emitter and light detector, the PPG pulsatile signal (i.e., detected light modulated by pulsatile blood flow) can decrease as the separation distance between the light emitter and light detector increases. On the other hand, perfusion index (i.e., the ratio of pulsatile signal amplitude versus DC light amplitude) can increase as the separation distance between the light emitter and light detector increases. Higher perfusion index tends to result in better rejection of noise due to motion (i.e., rejection of motion artifacts). Therefore, shorter separation distances between a light emitter and a light sensor can favor high PPG signal strength, while longer separation distances can favor high perfusion index (e.g., motion performance). That is, a trade-off can exist, making it difficult to optimize separation distance for particular user skin/tissue types and usage conditions. Additionally, the PPG system can include several light emitters, light detectors, components, and associated wiring that may be visible to a user’s eye, making the PPG system aesthetically unappealing. SUMMARY This relates to a PPG device configured with an architecture suitable for multiple light paths. The architecture can include one or more light emitters and one or more light sensors to generate the multiple light paths for measuring a PPG signal and a perfusion index of a user. The multiple light paths (i.e., the optical paths formed between each pair of light emitter and light detector) can include different locations and/or emitter-to-detector separation distances to generate both an accurate PPG signal and perfusion index value to accommodate a variety of users and a variety of usage conditions. In some examples, the multiple light paths can include different path locations, but the same separation distances along each path. In other examples, the multiple light paths can include overlapping, co-linear paths (i.e., along the same line) but with different emitter-to-detector separation distances along each path. In other examples, the multiple light paths can include different path locations and different emitter-to-detector separation distances along each path. In such examples, the particular configuration of the multiple light paths can be optimized for cancellation of noise due to artifacts resulting from, for example, tilt and/or pull of the device, a user’s hair, a user’s skin pigmentation, and/or motion. The PPG device can further include one or more lenses and/or reflectors to increase the signal strength and/or and to obscure the light emitters, light sensors, and associated wiring from being visible to a user’s eye.

Get Consumer Devices every Monday.

© 2026 Fearn AI, Inc. All rights reserved.

Information from the public patent record, not legal advice.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.

Big Law patents. In plain sight.

The all-in-one patent firm for startups. Former Big Law patent experts and PhDs, on AI that runs on our own GPUs.

Social

Newsletter

Stay updated on the future of intellectual property.

Fearn Legal, LLC is a patent prosecution firm, licensed to file and prosecute patents across the USPTO. The information provided here is for general informational purposes only and does not constitute legal advice. Viewing this information or contacting us through this website does not create an attorney-client or patent agent-client relationship. For personalized legal advice, please reach out to us directly to set up a legal consult or consult directly with a qualified attorney.